Therefore, we hypothesized MRTX1257 could reshape the immune microenvironment of CT26 KRASG12C+/+ tumors into a pro-inflammatory and anti-tumor phenotype that contributes to the radio-sensitizing effect observed in these tumors. The gene discussed is DDX53; the disease is neoplasm.